These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27601549)

  • 1. Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.
    Vose JM; Levit LA; Hurley P; Lee C; Thompson MA; Stewart T; Hofacker J; Bruinooge SS; Hayes DF
    J Clin Oncol; 2016 Nov; 34(31):3796-3802. PubMed ID: 27601549
    [No Abstract]   [Full Text] [Related]  

  • 2. Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.
    Bottomley A; Kirby T; Bean J; Walker J
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):43-5. PubMed ID: 23402444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.
    Bacon M; Kitchener H; Stuart GC; Vermorken JB;
    Int J Gynecol Cancer; 2011 May; 21(4):746-9. PubMed ID: 21543935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
    Frueh FW; Rudman A; Simon K; Gutman S; Reed C; Dorner AJ
    Pharmacogenomics J; 2006; 6(5):296-300. PubMed ID: 16568150
    [No Abstract]   [Full Text] [Related]  

  • 5. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
    Hammond AL; Waller EK; Finkelstein LB
    J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of life in cancer clinical trials: researchers, patients and policy makers.
    Dormer L
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):661-5. PubMed ID: 22098280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials and drug approvals continue to accelerate in China.
    Wang M
    Lancet Oncol; 2017 Jul; 18(7):855. PubMed ID: 28552212
    [No Abstract]   [Full Text] [Related]  

  • 8. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers in conducting clinical trials in oncology in the developing world: A cross-sectional survey of oncologists.
    Dandekar M; Trivedi R; Irawati N; Prabhash K; Gupta S; Agarwal JP; D'Cruz AK
    Indian J Cancer; 2016; 53(1):174-7. PubMed ID: 27146772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncology trial design: More accurately and efficiently advancing the field.
    Hohl RJ
    Clin Pharmacol Ther; 2015 May; 97(5):430-2. PubMed ID: 25684240
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging innovations in clinical trial design.
    Berry DA
    Clin Pharmacol Ther; 2016 Jan; 99(1):82-91. PubMed ID: 26561040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.
    Stuart GC; Kitchener H; Bacon M; duBois A; Friedlander M; Ledermann J; Marth C; Thigpen T; Trimble E; ;
    Int J Gynecol Cancer; 2011 May; 21(4):750-5. PubMed ID: 21543936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
    Felgenhauer J; Hooke MC
    Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
    Schnipper LE; Davidson NE; Wollins DS; Blayney DW; Dicker AP; Ganz PA; Hoverman JR; Langdon R; Lyman GH; Meropol NJ; Mulvey T; Newcomer L; Peppercorn J; Polite B; Raghavan D; Rossi G; Saltz L; Schrag D; Smith TJ; Yu PP; Hudis CA; Vose JM; Schilsky RL
    J Clin Oncol; 2016 Aug; 34(24):2925-34. PubMed ID: 27247218
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathology is a necessary and informative tool in oncology clinical trials.
    Nagtegaal ID; West NP; van Krieken JH; Quirke P
    J Pathol; 2014 Jan; 232(2):185-9. PubMed ID: 24037805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation.
    Lee M; Ly H; Möller CC; Ringel MS
    Clin Pharmacol Ther; 2019 Apr; 105(4):886-898. PubMed ID: 30636288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
    Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D
    J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of Authorship Restrictions for Research Studies in the American Society of Clinical Oncology Conflict of Interest Policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2017 Mar; 35(7):799-800. PubMed ID: 28113030
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
    Hurria A; Levit LA; Dale W; Mohile SG; Muss HB; Fehrenbacher L; Magnuson A; Lichtman SM; Bruinooge SS; Soto-Perez-de-Celis E; Tew WP; Postow MA; Cohen HJ;
    J Clin Oncol; 2015 Nov; 33(32):3826-33. PubMed ID: 26195697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.